![J. James Frost](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. James Frost
Directeur/Bestuurslid bij Applied Computational Technologies LLC
Profiel
J.
James Frost is currently a Director at Applied Computational Technologies LLC.
Previously, he held Director positions at DiaKine Therapeutics, Inc. and Pet Center, Inc. He also worked as a Professor at The Johns Hopkins University and Yale University.
Additionally, he was a Member of BlueTree Allied Angels LLC and a Section Chief at Nuclear Medicine Professionals, Inc. Frost earned a doctorate degree from the University of Washington.
Actieve functies van J. James Frost
Bedrijven | Functie | Begin |
---|---|---|
Applied Computational Technologies LLC
![]() Applied Computational Technologies LLC Medical/Nursing ServicesHealth Services Applied Computational Technologies LLC design and develops software for life sciences application in radiation treatment planning for cancer therapy. The company was founded by Jay McClatchey and Richard Andrew Holland in 2003 and is headquartered in Stoystown, PA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van J. James Frost
Bedrijven | Functie | Einde |
---|---|---|
DiaKine Therapeutics, Inc.
![]() DiaKine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DiaKine Therapeutics, Inc. is a start-up biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes. These drugs have the potential to restate the diabetes market by stopping the progression of diabetes and reversing damage already caused by the disease. Because of their unique immune modulating and anti-inflammatory properties, these therapies may potentially benefit people with type 1 and type 2 diabetes and represent a total available market opportunity of approximately $13 billion. The Company's lead compound, Lisofylline (LSF), has had an excellent safety profile in clinical trials to date. LSF works at the cellular level by improving the function of insulin producing islet cells and protecting them from damage and premature death caused when the body's immune system turns on itself. This autoimmune action is the cause of type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA), which combined affect approximately three million people in the U.S. About three million people with type 2 diabetes use insulin due to diminished insulin production and an increasing resistance to insulin. A primary focus of DiaKine's research and development is on its next generation of orally bioavailable immune modulators which have an improved spectrum of action to LSF. Two such compounds, DT22669 and DT23552, have been identified for further development and are examples of the extensive library of analogs and new structures in its patent portfolio that await discovery for future indications. | Directeur/Bestuurslid | - |
Nuclear Medicine Professionals, Inc.
![]() Nuclear Medicine Professionals, Inc. Finance/Rental/LeasingFinance Nuclear Medicine Professionals, Inc. provides ancillary nuclear cardiac imaging services. The company was founded by John E. Millett in 2001 and is headquartered in Gainesville, FL. | Corporate Officer/Principal | - |
Pet Center, Inc.
![]() Pet Center, Inc. Agricultural Commodities/MillingProcess Industries Pet Center, Inc. manufactures pet food. It offers chicken and biscuits, chicken nibbles, chicken breast tenders, super chews, beef-n-hide, beef jerky, cowearz, bully sticks, quackers, lamb crunchys, lammy chews, porky wafers, pigearz. The company is headquartered in Los Angeles, CA. | Directeur/Bestuurslid | - |
Yale University | Corporate Officer/Principal | - |
The Johns Hopkins University | Corporate Officer/Principal | - |
Opleiding van J. James Frost
University of Washington | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
DiaKine Therapeutics, Inc.
![]() DiaKine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DiaKine Therapeutics, Inc. is a start-up biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes. These drugs have the potential to restate the diabetes market by stopping the progression of diabetes and reversing damage already caused by the disease. Because of their unique immune modulating and anti-inflammatory properties, these therapies may potentially benefit people with type 1 and type 2 diabetes and represent a total available market opportunity of approximately $13 billion. The Company's lead compound, Lisofylline (LSF), has had an excellent safety profile in clinical trials to date. LSF works at the cellular level by improving the function of insulin producing islet cells and protecting them from damage and premature death caused when the body's immune system turns on itself. This autoimmune action is the cause of type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA), which combined affect approximately three million people in the U.S. About three million people with type 2 diabetes use insulin due to diminished insulin production and an increasing resistance to insulin. A primary focus of DiaKine's research and development is on its next generation of orally bioavailable immune modulators which have an improved spectrum of action to LSF. Two such compounds, DT22669 and DT23552, have been identified for further development and are examples of the extensive library of analogs and new structures in its patent portfolio that await discovery for future indications. | Health Technology |
Pet Center, Inc.
![]() Pet Center, Inc. Agricultural Commodities/MillingProcess Industries Pet Center, Inc. manufactures pet food. It offers chicken and biscuits, chicken nibbles, chicken breast tenders, super chews, beef-n-hide, beef jerky, cowearz, bully sticks, quackers, lamb crunchys, lammy chews, porky wafers, pigearz. The company is headquartered in Los Angeles, CA. | Process Industries |
BlueTree Allied Angels LLC
![]() BlueTree Allied Angels LLC Investment ManagersFinance BlueTree Allied Angels LLC (BlueTree Allied Angels) is a venture capital firm founded in 2003 by Catherine V. Mott and Tom Jones. The firm is headquartered in Wexford, Pennsylvania. | Finance |
Nuclear Medicine Professionals, Inc.
![]() Nuclear Medicine Professionals, Inc. Finance/Rental/LeasingFinance Nuclear Medicine Professionals, Inc. provides ancillary nuclear cardiac imaging services. The company was founded by John E. Millett in 2001 and is headquartered in Gainesville, FL. | Finance |
Applied Computational Technologies LLC
![]() Applied Computational Technologies LLC Medical/Nursing ServicesHealth Services Applied Computational Technologies LLC design and develops software for life sciences application in radiation treatment planning for cancer therapy. The company was founded by Jay McClatchey and Richard Andrew Holland in 2003 and is headquartered in Stoystown, PA. | Health Services |